IL1B and cancer: Tumor-promoting inflammation is emerging as a therapeutic target and one of the hallmarks of cancer [39], and prolonged stimulation with inflammatory cytokines, including IL-1β, has been implicated in the generation and accumulation of MDSCs [40, 41].